Kral M - Search Results

1

The Percentage of Free PSA and Urinary Markers Distinguish Prostate Cancer from Benign Hyperplasia and Contribute to a More Accurate Indication for Prostate Biopsy.

Huskova Z, Knillova J, Kolar Z, Vrbkova J, Kral M, Bouchal J. Huskova Z, et al. Among authors: kral m. Biomedicines. 2020 Jun 25;8(6):173. doi: 10.3390/biomedicines8060173. Biomedicines. 2020. PMID: 32630458 Free PMC article.

2

Urine markers in monitoring for prostate cancer.

Jamaspishvili T, Kral M, Khomeriki I, Student V, Kolar Z, Bouchal J. Jamaspishvili T, et al. Among authors: kral m. Prostate Cancer Prostatic Dis. 2010 Mar;13(1):12-9. doi: 10.1038/pcan.2009.31. Epub 2009 Aug 4. Prostate Cancer Prostatic Dis. 2010. PMID: 19652665 Review.

3

Genetic determinants of prostate cancer: a review.

Kral M, Rosinska V, Student V, Grepl M, Hrabec M, Bouchal J. Kral M, et al. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2011 Mar;155(1):3-9. doi: 10.5507/bp.155.2011.001. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2011. PMID: 21475371 Review.

4

Immunohistochemical localization and analysis of kallikrein-related peptidase 7 and 11 expression in paired cancer and benign foci in prostate cancer patients.

Jamaspishvili T, Scorilas A, Kral M, Khomeriki I, Kurfurstova D, Kolar Z, Bouchal J. Jamaspishvili T, et al. Among authors: kral m. Neoplasma. 2011;58(4):298-303. Neoplasma. 2011. PMID: 21520985

5

Androgen depletion induces senescence in prostate cancer cells through down-regulation of Skp2.

Pernicová Z, Slabáková E, Kharaishvili G, Bouchal J, Král M, Kunická Z, Machala M, Kozubík A, Souček K. Pernicová Z, et al. Among authors: kral m. Neoplasia. 2011 Jun;13(6):526-36. doi: 10.1593/neo.11182. Neoplasia. 2011. PMID: 21677876 Free PMC article.

6

Quadriplex model enhances urine-based detection of prostate cancer.

Jamaspishvili T, Kral M, Khomeriki I, Vyhnankova V, Mgebrishvili G, Student V, Kolar Z, Bouchal J. Jamaspishvili T, et al. Among authors: kral m. Prostate Cancer Prostatic Dis. 2011 Dec;14(4):354-60. doi: 10.1038/pcan.2011.32. Epub 2011 Jul 26. Prostate Cancer Prostatic Dis. 2011. PMID: 21788966

7

Relation of ETS transcription factor family member ERG, androgen receptor and topoisomerase 2β expression to TMPRSS2-ERG fusion status in prostate cancer.

Kolar Z, Burdova A, Jamaspishvili T, Bouchal J, Kucerova R, Bienova M, Kral M, Student V. Kolar Z, et al. Among authors: kral m. Neoplasma. 2014;61(1):9-16. Neoplasma. 2014. PMID: 24195515

8

Androgenetic alopecia and polymorphism of the androgen receptor gene (SNP rs6152) in patients with benign prostate hyperplasia or prostate cancer.

Kucerova R, Bienova M, Kral M, Bouchal J, Trtkova KS, Burdova A, Student V, Kolar Z. Kucerova R, et al. Among authors: kral m. J Eur Acad Dermatol Venereol. 2015 Jan;29(1):91-6. doi: 10.1111/jdv.12468. Epub 2014 Mar 25. J Eur Acad Dermatol Venereol. 2015. PMID: 24665929

9

The role of high cell density in the promotion of neuroendocrine transdifferentiation of prostate cancer cells.

Pernicová Z, Slabáková E, Fedr R, Šimečková Š, Jaroš J, Suchánková T, Bouchal J, Kharaishvili G, Král M, Kozubík A, Souček K. Pernicová Z, et al. Among authors: kral m. Mol Cancer. 2014 May 20;13:113. doi: 10.1186/1476-4598-13-113. Mol Cancer. 2014. PMID: 24884804 Free PMC article.

10

Opposite regulation of MDM2 and MDMX expression in acquisition of mesenchymal phenotype in benign and cancer cells.

Slabáková E, Kharaishvili G, Smějová M, Pernicová Z, Suchánková T, Remšík J, Lerch S, Straková N, Bouchal J, Král M, Culig Z, Kozubík A, Souček K. Slabáková E, et al. Among authors: kral m. Oncotarget. 2015 Nov 3;6(34):36156-71. doi: 10.18632/oncotarget.5392. Oncotarget. 2015. PMID: 26416355 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

180 results

Search Page